chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 02Apr2021 as dose 1, single (Lot number: ER2613), in right arm, on 06May2021 as dose 2, single (Lot number: ER8731), in right arm and on 06Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 38 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (21Oct2022) Negative, notes: By day 6 he had recovered and tested negative consistently; (23Oct2022) Positive, notes: Day 8, mild symptoms reappeared and he again tested positive; (24Oct2022) Positive, notes: From days 8-11 he was experiencing escalating, but mild symptoms (sore throat, cough, runny nose) and continue to test positive; (25Oct2022) Positive, notes: From days 8-11 he was experiencing escalating, but mild symptoms (sore throat, cough, runny nose) and continue to test positive; (26Oct2022) Positive, notes: From days 8-11 I am experiencing escalating, but mild symptoms (sore throat, cough, runny nose) and continue to test positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: It was reported that, the patient did not receive any other medications in 2 weeks. Anti-viral details were Paxlovid from 16Oct2022 to 20Oct2022 for Covid-19 treatment. He took Paxlovid as soon as symptoms appeared, taking the standard 5-day course. Days 1-3 he was very unwell, with high fever, aches etc. By day 6 he had recovered and tested negative consistently. Day 8, mild symptoms reappeared, and he again tested positive. From days 8-11 I am experiencing escalating, but mild symptoms (sore throat, cough, runny nose) and continue to test positive. No Known allergies and no other medical history.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv vax & devel chickenpox w/lesions all over body;MD reported 73 lesions;5/4/98 pt devel a fever of 101;
Covid vaccine administered to patient in her right arm at 2;34 pm and patient fainted. Staff administering the vaccine immediately provided assistance and patient did not fall out of chair nor was was there any injury as a result the syncope episode. Patient recovered quickly and was given water. Initial BP and heart rate 93/43 and 64, At 2:53 pm vital signs were BP{ 98/53, HR 64, T 98.6, R 18 and  BG 108. Vital signs at 3:10 pm BP 102/53 and HR 59. Patient was alert and oriented. Patient stated she feels okay, and denied lightheadedness or dizziness. Gait noted to be steady without stumbling, swaying, or falling.  Patient was observed from 2;34 pm to 3;15 pm.
On 4/24/00, the pt received the first dose of Havrix, one month later, on 5/24/00, the pt experienced fainting. As of 10/24/00, the outcome of the event is unknown.
Narrative: Pt with tinnitus, stated that he got more ringing in the ear after this second dose of Pfizer vaccine.
The titres showed sufficient antibodies to only 12 of the 23 serotypes contained in the vaccine; This spontaneous report as received from a nurse practitioner refers to a currently 63-year-old female patient. The patient did not have any known drug reactions or allergies. No information regarding the patient's pertinent medical history and concomitant therapies was provided.  On an unknown date in May 2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) intramuscularly (dose, lot # and expiration date were not reported) for prophylaxis.  On an unknown date in 2019, the patient had a pneumococcal antibody titres performed and it showed sufficient antibodies to only 12 of the 23 serotypes contained in the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23). No other adverse effects were reported in the patient. No treatment was given for the event. The patient did not seek medical attention.  The outcome of the event was reported as not recovered/not resolved.  The relatedness between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.
dizzy; feeling of beginning to fall; tingly toes and legs; could not stand on her legs, did not feel well legs don't feel right; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), DEPRESSED MOOD (feeling of beginning to fall), PARAESTHESIA (tingly toes and legs) and DYSSTASIA (could not stand on her legs, did not feel well legs don't feel right) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included GLIPIZIDE for Diabetes mellitus, MECLOZINE HYDROCHLORIDE (MECLIZINE [MECLOZINE HYDROCHLORIDE]) for Dizziness, METFORMIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), PREDNISOLONE and CEFALEXIN MONOHYDRATE (KEFLEX [CEFALEXIN MONOHYDRATE]) for an unknown indication.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, the patient experienced DIZZINESS (dizzy), DEPRESSED MOOD (feeling of beginning to fall), PARAESTHESIA (tingly toes and legs) and DYSSTASIA (could not stand on her legs, did not feel well legs don't feel right). The patient was treated with SALINE [SODIUM CHLORIDE] (intravenous) at an unspecified dose and frequency. On 25-May-2021, DIZZINESS (dizzy), DEPRESSED MOOD (feeling of beginning to fall), PARAESTHESIA (tingly toes and legs) and DYSSTASIA (could not stand on her legs, did not feel well legs don't feel right) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The treatment medication was antibiotic.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Follow up received and contains No new information.
Per patient's Alert profile, he received first dose Pfizer, second dose Moderna, and boost Moderna.  In Alert, the 2nd dose and booster are not valid.
Nausea- 8 hours following the vaccine and lasted until 29 hours after  Vomit- one time about 9 hours after the vaccine   Frequent Bowel Movement- every time I ate for 36 hours after vaccine, however stool was solid   Sore arm- started 6 hours after and lasted until 48 hours after   Ear ache in Right ear-  started 12 hours after and lasted until 24 hours after
patient was brought to ER from  nursing home due to hypoxemia. Patient was satting in the mid-40s on non-rebreather and was intubated emergently when brought to the ER. ICU was called for admission. Patient is hospitalized due to COVID-19. Patient is fully vaccinated.
I had Covid but this almost killed me temp for 2 days 102.8 worst headache I ever had lymph nodes swollen under armpit body aches bad earaches.I will not take the second dose it will kill me.Had to be out of work had no energy to get out of bed.Still extremely weak and fatigued.
This case was reported by a healthcare professional and described the occurrence of hepatitis B surface antigen positive in a 67-year-old male subject who was vaccinated with Engerix B for prophylaxis.  Concurrent medical conditions included diabetes and hemodialysis.  Concurrent medications included Venofer, Paricalcitol (Zemplar), Epoetin alfa (Epogen), Metoclopramide hydrochloride (Reglan), Simvastatin, Aspirin, Cosopt, and Human Insulin (Novolin).  On 18 June 2007 the subject received 3rd dose of Engerix B at 40 mcg.  On 20 June 2007, two days after vaccination with Engerix B, the subject was tested and found to be hepatitis B surface antigen positive.  At the time of reporting the outcome of the event was unspecified.  Follow-up information was received from the reporting nurse.  The reporter did not consider the event to be serious.  On 27 June 2007, hepatitis B surface antigen was negative.  Per the reporter, the immunization series was not delayed or discontinued.  No symptoms recurred following subsequent administration of Engerix B.  The subject had not experienced any adverse events following previous vaccinations.
PATIENT SAID HER ARM GOT SWOLLEN FROM ELBOW TO SHOULDER AND VERY SORE THAT SHE COULD BEARLY MOVE FOR ABOUT A WEEK AFTER 1ST DOSE OF SHINGRIX
Autoimmune issue; myasthenia gravis; This spontaneous case was reported by a consumer and describes the occurrence of AUTOIMMUNE DISORDER (Autoimmune issue) and MYASTHENIA GRAVIS (myasthenia gravis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AUTOIMMUNE DISORDER (Autoimmune issue) (seriousness criteria hospitalization and medically significant) and MYASTHENIA GRAVIS (myasthenia gravis) (seriousness criteria hospitalization and medically significant). The patient was treated with Physical therapy for Autoimmune disorder. At the time of the report, AUTOIMMUNE DISORDER (Autoimmune issue) had not resolved and MYASTHENIA GRAVIS (myasthenia gravis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No additional treatment information was provided.  The treatment included therapy. This spontaneous case was reported by a consumer and describes the occurrence of AUTOIMMUNE DISORDER (Autoimmune issue) and Myasthenia gravis (Myasthenia gravis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AUTOIMMUNE DISORDER (Autoimmune issue) (seriousness criteria hospitalization and medically significant) and Myasthenia gravis (Myasthenia gravis) (seriousness criteria hospitalization and medically significant). At the time of the report, AUTOIMMUNE DISORDER (Autoimmune issue) had not resolved and Myasthenia gravis (Myasthenia gravis) (seriousness criteria hospitalization and medically significant) was not resolved.  Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
This spontaneous report as received from a Registered Nurse refers to a female adult patient of unknown age. The patient was administered a dose of TWINRIX (lot# unspecified) (dose, route and location unspecified) on 30-AUG-2011, a second dose of TWINRIX (lot# unspecified) (dose, route and location unspecified) on 04-OCT-2011, a dose of RECOMBIVAX HB (lot# unspecified) (dose, route and location unspecified) on an unspecified date after 04-OCT-2011. No adverse event was reported. This is one of several reports received from the same reporter. Additional information is not expected.
Myocardolitis (+) ESR (+) troponin wall motion abnormality negative angiogram
patient passed out shortly(3-5 minutes) after receiving her vaccine.  Patient got dizzy, fuzzy then blacked out for about 30 seconds then came to. After a few minutes patient was feeling better and left about 20-30 minutes after incident.
Redness; Swelling; Headache; This case was reported by a physician via sales rep and described the occurrence of erythema in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced erythema, swelling and headache. On an unknown date, the outcome of the erythema, swelling and headache were unknown.   It was unknown if the reporter considered the erythema, swelling and headache to be related to Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced redness, swelling, and headache that persisted for a few days. The reporter did not agreed to follow up with GlaxoSmithKline
had a headache; didn't feel well; body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 15:00 (Lot number: EW0162) at the age of 59 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: CALCIUM taken for osteoporosis; EMERGEN-C taken for osteoporosis. Vaccination history included: Bnt162b2 (Dose 1, Lot number: ER8733 , Anatomical location : Left arm), administration date: 07Apr2021, when the patient was 59 years old, for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 30Apr2021, outcome "recovering", described as "had a headache"; MALAISE (non-serious) with onset 30Apr2021, outcome "recovered" (May2021), described as "didn't feel well"; PAIN (non-serious) with onset 30Apr2021, outcome "recovered" (May2021), described as "body aches". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache..  Additional information:The caller reported that she has had both doses of the vaccine, her last dose being on 30Apr2021. She has had a persisting headache since the day of the second vaccine. She has been taking Advil around the clock every 5 to 6 hours, and now every 6-7 hours. It is starting to improve slightly. She has not seen the doctor yet. She said she had her second COVID-19 Vaccine shot on 30Apr2021, and had a headache and didn't feel well. She said 15 days later, she still had a headache. She said she had been checking her blood pressure, since she had the headache, and she had no blood pressure issues. She said her headache has been persistent. Reported she takes no prescription products. She said for the past 2-4 years, she has took calcium, vitamins, and Emergen-C because her doctor told her she was starting to lose bone (density). Reported she had no medical conditions, and goes every October for her annual checks up with doctor, gynecologist, and dentist. when she first got her second COVID-19 Vaccine, she was OK when she came home. She said somewhere between 11:00PM and midnight, she had a headache start, and she was not feeling well, and had body aches. She said she knew those were expected COVID-19 Vaccine side effects, so she was fine. She said she drank a lot of fluids, and rested over Saturday (01May2021), and had chicken soup. She said by Sunday (02May2021), she felt much better, and everything had gone away, except her headache. The patient did not require to visit Emergency Room or Physician Office because of events. The patient did have another vaccine prior 4 weeks of vaccination. The patient did not experience any event prior vaccination. The patient medical History (including any illness at time of vaccination) reported as none. The patient family history not provided. The relevant test reported as none.  No follow-up attempts are possible. No further information is expected.
1st day slight feeling in shoulder. April 6 approx 10 AM my shoulder started to hurt. Over that day and the next week, sight began to swell, get hard, feel warm. The size of the swelling was between a baseball and a softball that was cut in half. It became itchy and turned red. These symptoms continue to this day. Tho the swelling is less and the warmth is diminishing as is the red. My temp was taken during this time. It was and remains normal
Gave a patient his first dose / medicine ran down his arm; Gave a patient his first dose / medicine ran down his arm; This case was reported by a pharmacist via call center representative and described the occurrence of inadvertent exposure to vaccine in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number LL2G7, expiry date 31st October 2022) for prophylaxis.   On 13th June 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 13th June 2021, unknown after receiving Shingrix, the patient experienced inadvertent exposure to vaccine and exposure via skin contact. On an unknown date, the outcome of the inadvertent exposure to vaccine and exposure via skin contact were unknown.   It was unknown if the reporter considered the inadvertent exposure to vaccine and exposure via skin contact to be related to Shingrix.  Additional details were provided as follow: The reporter stated that she gave a patient dose of Shingrix in left deltoid and the medicine ran down his arm, which led to inadvertent exposure to vaccine and exposure via skin contact. The patient was not happy and wanted to know what steps needs to be taken. The reporter consented to follow up
Mom states child had varivax vaccine but has now been diagnosed with chicken pox 1-10-2005.  Call mom for further info.
Acute on chronic anemia -  Patient was admitted on telemetry started on Protonix drip and patient was given 3 unit blood transfusions.  She has remained hemodynamically stable even at arrival, no further acute loss identified. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
bladder infection; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date the patient experienced bladder infection and was prescribed to take 2 antibiotics, one of which is fosfomycin. The patient asked if it is safe for her to get the second shot of the COVID-19 vaccine as it is scheduled on 18Feb2021 and if it would affect the vaccine. The event's outcome was unknown at the time of the report.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
COUGH AND CONGESTION, RASH OVER TORSO, ITCHING AND RED BUMPS.
PT. WOKE UP WITH 2 SORE ARMS. LARGE HOT VERY RED CLEARLY DEFINED AREAS ON UPPER OUTER ARMS. BOTH ARMS SORE. FEELS MALAISE.
02/03-02/04/2021 TEMPERATURE 100.5 *F, TREATMENT WITH TYLENOL. 02/05/2021 FELT WORSE IN THE MORNING, TREATMENT WITH ALEVE, FELT BETTER. EVENING BEGAN TO HAVE CHEST PAIN, BODYACHE, NECK/JAW PAIN - WENT TO EMERGENCY ROOM. CARDIAC LABS ELEVATED ADMITTED TO HOSPITAL. ALL OTHER TESTS CAME BACK WITHIN LIMITS BUT CATH NOT AVAILABLE ON THE SEEKENDS SO HELD. PATIENT CATH WAS CLEAR, RELEASED APPROX 1600 02/08/2021 WITH INSTRUCTIONS TO FOLLOW-UP WITH PCM. PCM APPOINTMENT SCHEDULED FOR 02/12/2021.
Extreme vertigo; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 16:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included meniere's disease, hypothyroidism and high blood pressure. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC), sertraline (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all were taken for an unknown indication from an unknown date and unknown if ongoing. On 03Mar2021 at 11:00 (also reported lasted for 6 hours), the patient experienced extreme vertigo and had to lay down on the floor at work and it lasted about 6 hours. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with unspecified decongestant and fever reducer. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme vertigo was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Chills (24 hours), Medicine for Colitis failed resulting in diarrhea.
On the next day after myCovid vaccine booster shot. I had the following Fever  shivering Headache  Whole body ache  Huge lymph node lump as the size of ping pong ball, in the left armpit. Same arm I took the shot in
Area that received vaccination (left arm) is swollen to the size of hand; hard and warm to touch; hurts when raise arm; Patient has no other medical problems; suggested ALEVE and hydrocortisone cream of which she took and she said will take BENADRYL.  Spoke to the manufacturer of Pneumovax and they suggest going to emergency room, which was relayed to patient per person mentioned.
Excessive swelling and redness of left upper arm. Sought treatment from MD; Prednisone prescribed.
Pt presented in the clinic requesting required vaccines for school attendance. Pt did not have immunization records from previous residence and first dose of HEP A was given 9/19/2022.  HEP A was given at a too short interval.
02/28/2023 Mom called the office at 10:40am and stated that the school nurse had called her and said her daughter was having an allergic reaction to the vaccine. I asked her what was going on and she stated that her daughters arm was swelling up at the site and was red and warm to the touch. I told her that wasn't an allergic reaction and to apply some ice to the area. I also told her to call EMS or take her to the ER if she experienced any swelling of the face or throat, and difficulty breathing, that these symptoms would be an allergic reaction and would be an emergency. I let her know the redness, swelling, and warmth should go away in 3-4 days. I told her to call us back if she had any other questions or concerns. Mom said ok and hung up.